Key financial indicators
Overview of key financial indicators in 1-9 2018
| Sales (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,088.1 | 2,979.5 | 3.6% |
| Sales revenues of Podravka Group | 3,078.3 | 2,983.1 | 3.2% |
| Sales revenues of Food | 2,439.0 | 2,372.3 | 2.8% |
| Sales revenues of Pharma | 639.3 | 610.8 | 4.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Group's gross profit | 1,144.2 | 1,061.7 | 7.8% |
| Group's gross profit margin | 37.2% | 35.6% | +158 bp |
| Group's EBITDA | 379.4 | 254.4 | 49.1% |
| Group's EBITDA margin | 12.3% | 8.5% | +380 bp |
| Group's EBIT | 238.8 | 110.5 | 116.0% |
| Group's EBIT margin | 7.8% | 3.7% | +405 bp |
| Group's net profit after MI | 185.9 | 54.1 | 243.8% |
| Group's net profit margin after MI | 6.0% | 1.8% | +423 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2018 | 31.12.2017 | % change |
| Total assets | 4,848.1 | 5,061.4 | (0.0%) |
| Shareholders' equity | 2,987.1 | 2,860.1 | 4.4% |
| Minority interests | 40.5 | 36.7 | 10.5% |
| Cash and cash equivalents | 146.0 | 362.1 | (0.6%) |
| Financial debt | 1,015.1 | 1,271.1 | (0.2%) |
| Net debt | 869.1 | 909.1 | (0.0%) |
| Podravka Group's cash flow (in HRKm) | 1-9 2018 | 1-9 2017 | % change |
| Net cash flow from operating activities | 146.6 | 193.1 | (0.2%) |
| Capital expenditures | 108.5 | 158.8 | (0.3%) |
| Depreciation and amortization | 140.6 | 143.8 | (0.0%) |
| Free cash flow | 38.1 | 34.3 | 11.0% |
| Podravka Group's ratios and indicators | 30.09.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,626 | 6,306 | 5.1% |
| P&L interest expense (in HRKm) | 20.5 | 26.9 | (0.2%) |
| Sales revenues / Number of employees (in HRK000) | 634.8 | 651.9 | (0.0%) |
| Net profit after MI / Sales revenues (in HRK000) | 22.7 | 2.9 | 682.8% |
| Return on average assets | 3.1% | 0.5% | +266 bp |
| Return on average capital | 5.2% | 0.8% | +439 bp |
| Return on average invested capital | 4.7% | 1.9% | +275 bp |
| Total shareholders' equity / Total assets | 62.5% | 57.2% | +522 bp |
| EBIT / P&L interest expense | 10.7 | 3.4 | 216.1% |
| Net debt / EBITDA | 1.7 | 2.4 | (0.3%) |
| Sales (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,031.7 | 1,944.0 | 4.5% |
| Sales revenues of Podravka Group | 2,035.1 | 1,951.2 | 4.3% |
| Sales revenues of Food | 1,602.2 | 1,544.4 | 3.7% |
| Sales revenues of Pharma | 432.8 | 406.8 | 6.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
| Group's gross profit | 760.6 | 693.7 | 9.7% |
| Group's gross profit margin | 37.4% | 35.6% | +182 bp |
| Group's EBITDA | 243.5 | 140.0 | 74.0% |
| Group's EBITDA margin | 12.0% | 7.2% | +479 bp |
| Group's EBIT | 149.2 | 44.8 | 233.2% |
| Group's EBIT margin | 7.3% | 2.3% | +504 bp |
| Group's net profit after MI | 120.7 | 24.8 | 386.7% |
| Group's net profit margin after MI | 5.9% | 1.3% | +466 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2018 | 31.12.2017 | % change |
| Total assets | 4,852.9 | 5,061.4 | -4.1% |
| Shareholders' equity | 2,915.9 | 2,860.1 | 2.0% |
| Minority interests | 38.1 | 36.7 | 3.9% |
| Cash and cash equivalents | 211.1 | 362.1 | -41.7% |
| Financial debt | 1,069.0 | 1,271.1 | -15.9% |
| Net debt | 857.9 | 909.1 | -5.6% |
| Podravka Group's cash flow (in HRKm) | 1-6 2018 | 1-6 2017 | % change |
| Net cash flow from operating activities | 99.0 | 136.7 | -27.6% |
| Capital expenditures | 67.4 | 122.9 | -45.2% |
| Depreciation and amortization | 94.3 | 95.2 | -0.9% |
| Free cash flow | 31.6 | 13.8 | 128.9% |
| Podravka Group's ratios and indicators | 30.06.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,531 | 6,306 | 3.6% |
| P&L interest expense (in HRKm) | 23.4 | 26.9 | -13.0% |
| Sales revenues / Number of employees (in HRK000) | 642.3 | 651.9 | -1.5% |
| Net profit after MI / Sales revenues (in HRK000) | 17.5 | 2.9 | 503.8% |
| Return on average assets | 2.4% | 0.5% | +190 bp |
| Return on average capital | 4.0% | 0.8% | +318 bp |
| Return on average invested capital | 4.2% | 1.9% | +229 bp |
| Total shareholders' equity / Total assets | 60.9% | 57.2% | +364 bp |
| EBIT / P&L interest expense | 8.4 | 3.4 | 146.7% |
| Net debt / EBITDA | 1.8 | 2.4 | -26.1% |
| Sales (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 987.1 | 919.5 | 7.3% |
| Sales revenues of Podravka Group | 988.9 | 913.2 | 8.3% |
| Sales revenues of Food | 789.8 | 723.6 | 9.2% |
| Sales revenues of Pharma | 199.0 | 189.6 | 5.0% |
| Podravka Group's profitability (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
| Group's gross profit | 372.2 | 325.3 | 14.4% |
| Group's gross profit margin | 37.6% | 35.6% | +201 bp |
| Group's EBITDA | 135.6 | 75.8 | 78.9% |
| Group's EBITDA margin | 13.7% | 8.3% | +541 bp |
| Group's EBIT | 87.7 | 28.2 | 210.7% |
| Group's EBIT margin | 8.9% | 3.1% | +578 bp |
| Group's net profit after MI | 69.8 | 18.0 | 287.3% |
| Group's net profit margin after MI | 7.1% | 2.0% | +509 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2018 | 31.12.2017 | % change |
| Total assets | 4,902.4 | 5,061.4 | -3.1% |
| Shareholders' equity | 2,921.8 | 2,860.1 | 2.2% |
| Minority interests | 37.9 | 36.7 | 3.3% |
| Cash and cash equivalents | 195.8 | 362.1 | -45.9% |
| Financial debt | 1,161.3 | 1,271.1 | -8.6% |
| Net debt | 965.5 | 909.1 | 6.2% |
| Podravka Group's cash flow (in HRKm) | 1-3 2018 | 1-3 2017 | % change |
| Net cash flow from operating activities | (41.4) | 48.1 | -186.0% |
| Capital expenditures | 24.5 | 84.7 | -71.1% |
| Depreciation and amortization | 47.9 | 47.6 | 0.7% |
| Free cash flow | (65.9) | (36.6) | 80.2% |
| Podravka Group's ratios and indicators | 31.03.2018 | 31.12.2017 | % change |
| Employee number at the end of period (in units) | 6,407 | 6,306 | 1.6% |
| P&L interest expense (in HRKm) | 25.0 | 26.9 | -7.0% |
| Sales revenues / Number of employees (in HRK000) | 653.5 | 651.9 | 0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 10.9 | 2.9 | 277.7% |
| Return on average assets | 1.5% | 0.5% | +102 bp |
| Return on average capital | 2.5% | 0.8% | +170 bp |
| Return on average invested capital | 3.2% | 1.9% | +127 bp |
| Total shareholders' equity / Total assets | 60.4% | 57.2% | +314 bp |
| EBIT / P&L interest expense | 6.0 | 3.4 | 77.4% |
| Net debt / EBITDA | 2.2 | 2.4 | -8.4% |
| Sales (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,110.9 | 4,226.5 | -2.7% |
| Sales revenues of Podravka Group | 4,111.2 | 4,185.5 | -1.8% |
| Sales revenues of Food | 3,243.7 | 3,370.3 | -3.8% |
| Sales revenues of Pharma | 867.5 | 815.2 | 6.4% |
| Podravka Group's profitability (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
| Group's gross profit | 1,484.1 | 1,535.2 | -3.3% |
| Group's gross profit margin | 36.1% | 36.7% | -58 bp |
| Group's EBITDA | 374.1 | 471.3 | -20.6% |
| Group's EBITDA margin | 9.1% | 11.3% | -216 bp |
| Group's EBIT | 91.1 | 268.9 | -66.1% |
| Group's EBIT margin | 2.2% | 6.4% | -421 bp |
| Group's net profit after MI | 18.2 | 182.4 | -90.0% |
| Group's net profit margin after MI | 0.4% | 4.4% | -391 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2017 | 31.12.2016 | % change |
| Total assets | 5,061.4 | 5,285.7 | -4.2% |
| Shareholders' equity | 2,860.1 | 2,877.2 | -0.6% |
| Minority interests | 36.7 | 49.2 | -25.5% |
| Cash and cash equivalents | 362.1 | 337.6 | 7.2% |
| Financial debt | 1,271.1 | 1,379.4 | -7.8% |
| Net debt | 909.1 | 1,041.7 | -12.7% |
| Podravka Group's cash flow (in HRKm) | 1-12 2017 | 1-12 2016 | % change |
| Net cash flow from operating activities | 473.4 | 476.7 | -0.7% |
| Capital expenditures | 206.8 | 437.1 | -52.7% |
| Depreciation and amortization | 194.0 | 191.4 | 1.4% |
| Free cash flow | 250.8 | 39.6 | 533.0% |
| Podravka Group's ratios and indicators | 2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,306 | 6,404 | -1.5% |
| P&L interest expense (in HRKm) | 26.9 | 31.5 | -14.6% |
| Sales revenues / Number of employees (in HRK000) | 651.9 | 653.6 | -0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 2.9 | 28.5 | -89.8% |
| Return on average assets | 0.5% | 3.7% | -321 bp |
| Return on average capital | 0.8% | 6.5% | -572 bp |
| Return on average invested capital | 1.9% | 5.7% | -380 bp |
| Total shareholders' equity / Total assets | 57.2% | 55.4% | +187 bp |
| EBIT / P&L interest expense | 3.4 | 8.5 | -60.3% |
| Net debt / EBITDA | 2.4 | 2.2 | 9.9% |
| Sales (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,979.5 | 3,049.4 | -2.3% |
| Sales revenues of Podravka Group | 2,983.1 | 3,030.8 | -1.6% |
| Sales revenues of Food | 2,372.4 | 2,465.2 | -3.8% |
| Sales revenues of Pharma | 610.7 | 565.6 | 8.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
| Group's gross profit | 1,059.4 | 1,104.1 | -4.0% |
| Group's gross profit margin | 35.5% | 36.4% | -91 bb |
| Group's EBITDA | 254.4 | 337.4 | -24.6% |
| Group's EBITDA margin | 8.5% | 11.1% | -260 bb |
| Group's EBIT | 110.5 | 201.2 | -45.1% |
| Group's EBIT margin | 3.7% | 6.6% | -293 bb |
| Group's net profit after MI | 54.1 | 142.2 | -62.0% |
| Group's net profit margin after MI | 1.8% | 4.7% | -288 bb |
| Podravka Group's balance sheet (in HRKm) | 30.09.2017 | 31.12.2016 | % change |
| Total assets | 5,072.9 | 5,285.7 | -4.0% |
| Shareholders' equity | 2,890.2 | 2,877.2 | 0.5% |
| Minority interests | 36.3 | 49.2 | -26.2% |
| Cash and cash equivalents | 178.6 | 337.6 | -47.1% |
| Financial debt | 1,326.4 | 1,379.4 | -3.8% |
| Net debt | 1,147.8 | 1,041.7 | 10.2% |
| Podravka Group's cash flow (in HRKm) | 1-9 2017 | 1-9 2016 | % change |
| Net cash flow from operating activities | 193.1 | 299.3 | -35.5% |
| Capital expenditures | 158.8 | 383.7 | -58.6% |
| Depreciation and amortization | 143.8 | 136.1 | 5.7% |
| Free cash flow | 34.3 | -84.4 | n/p |
| Podravka Group's ratios and indicators | 30.09.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,620 | 6,404 | 3.4% |
| P&L interest expense (in HRKm) | 26.8 | 31.5 | -15.0% |
| Sales revenues / Number of employees (in HRK000) | 625.0 | 653.6 | -4.4% |
| Net profit after MI / Sales revenues (in HRK000) | 14.2 | 28.5 | -50.0% |
| Return on average assets | 1.9% | 3.7% | -173 bp |
| Return on average capital | 3.4% | 6.5% | -310 bp |
| Return on average invested capital | 3.6% | 5.7% | -213 bp |
| Total shareholders' equity / Total assets | 57.7% | 55.4% | +232 bp |
| EBIT / P&L interest expense | 6.7 | 8.5 | -22.1% |
| Net debt / EBITDA | 3.0 | 2.2 | 33.8% |
| Sales (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,955.3 | 1,998.4 | -2.2% |
| Sales revenues of Podravka Group | 1,951.2 | 1,988.5 | -1.9% |
| Sales revenues of Food | 1,544.4 | 1,609.5 | -4.0% |
| Sales revenues of Pharma | 406.8 | 379.1 | 7.3% |
| Podravka Group's profitability (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
| Group's gross profit | 689.3 | 723.8 | -4.8% |
| Group's gross profit margin | 35.3% | 36.4% | -107 bp |
| Group's EBITDA | 140.0 | 222.0 | -36.9% |
| Group's EBITDA margin | 7.2% | 11.2% | -399 bp |
| Group's EBIT | 44.8 | 129.8 | -65.5% |
| Group's EBIT margin | 2.3% | 6.5% | -423 bp |
| Group's net profit after MI | 24.8 | 97.3 | -74.5% |
| Group's net profit margin after MI | 1.3% | 4.9% | -362 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2017 | 31.12.2016 | % change |
| Total assets | 5,112.1 | 5,285.7 | -3.3% |
| Shareholders' equity | 2,895.6 | 2,877.2 | 0.6% |
| Minority interests | 51.1 | 49.2 | 3.9% |
| Cash and cash equivalents | 285.8 | 337.6 | -15.3% |
| Financial debt | 1,370.2 | 1,379.4 | -0.7% |
| Net debt | 1,084.4 | 1,041.7 | 4.1% |
| Podravka Group's cash flow (in HRKm) | 1-6 2017 | 1-6 2016 | % change |
| Net cash flow from operating activities | 136.7 | 142.0 | -3.7% |
| Capital expenditures | 122.9 | 233.1 | -47.3% |
| Depreciation and amortization | 95.2 | 92.2 | 3.2% |
| Free cash flow | 13.8 | -91.1 | n/a |
| Podravka Group's ratios and indicators | 30.06.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,432 | 6,404 | 0.4% |
| P&L interest expense (in HRKm) | 27.7 | 31.5 | -11.9% |
| Sales revenues / Number of employees (in HRK000) | 644.9 | 653.6 | -1.3% |
| Net profit after MI / Sales revenues (in HRK000) | 17.1 | 28.5 | -40.0% |
| Return on average assets | 2.3% | 3.7% | -142 bp |
| Return on average capital | 4.0% | 6.5% | -255 bp |
| Return on average invested capital | 3.8% | 5.7% | -195 bp |
| Total shareholders' equity / Total assets | 57.6% | 55.4% | +228 bp |
| EBIT / P&L interest expense | 6.6 | 8.5 | -22.3% |
| Net debt / EBITDA | 2.8 | 2.2 | 26.1% |
| Sales (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 915.5 | 1,002.9 | -8.7% |
| Sales revenues of Podravka Group | 913.2 | 997.1 | -8.4% |
| Sales revenues of Food | 723.6 | 814.6 | -11.2% |
| Sales revenues of Pharma | 189.6 | 182.5 | 3.9% |
| Podravka Group's profitability (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Group's gross profit | 320.6 | 365.5 | -12.3% |
| Group's gross profit margin | 35.1% | 36.7% | -154 bp |
| Group's EBITDA | 75.8 | 126.9 | -40.3% |
| Group's EBITDA margin | 8.3% | 12.7% | -442 bp |
| Group's EBIT | 28.2 | 81.1 | -65.2% |
| Group's EBIT margin | 3.1% | 8.1% | -504 bp |
| Group's net profit after MI | 18.0 | 60.1 | -70.0% |
| Group's net profit margin after MI | 2.0% | 6.0% | -405 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2017 | 31.12.2016 | % change |
| Total assets | 5,182.2 | 5,285.7 | -2.0% |
| Shareholders' equity | 2,890.0 | 2,877.2 | 0.4% |
| Minority interests | 50.2 | 49.2 | 2.0% |
| Cash and cash equivalents | 250.5 | 337.6 | -25.8% |
| Financial debt | 1,338.1 | 1,379.4 | -3.0% |
| Net debt | 1,087.6 | 1,041.7 | 4.4% |
| Podravka Group's cash flow (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Net cash flow from operating activities | 48.1 | -5.0 | n/a |
| Capital expenditures | 84.7 | 121.1 | -30.0% |
| Depreciation and amortization | 47.6 | 45.8 | 3.9% |
| Free cash flow | -36.6 | -126.0 | -71.0% |
| Podravka Group's ratios and indicators | 31.03.2017 | 2016 | % change |
| Employee number at the end of period (in units) | 6,497 | 6,404 | 1.5% |
| P&L interest expense (in HRKm) | 29.4 | 31.5 | -6.5% |
| Sales revenues / Number of employees (in HRK000) | 631.3 | 653.6 | -3.4% |
| Net profit after MI / Sales revenues (in HRK000) | 21.6 | 28.5 | -24.2% |
| Return on average assets | 2.8% | 3.7% | -83 bp |
| Return on average capital | 5.0% | 6.5% | -150 bp |
| Return on average invested capital | 4.4% | 5.7% | -129 bp |
| Total shareholders' equity / Total assets | 56.7% | 55.4% | +137 bp |
| EBIT / P&L interest expense | 7.3 | 8.5 | -14.1% |
| Net debt / EBITDA | 2.6 | 2.2 | 17.1% |
| Sales (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,226.5 | 3,761.1 | 12.4% |
| Sales revenues of Podravka Group | 4,185.5 | 3,626.8 | 15.4% |
| Sales revenues of Food | 3,370.3 | 2,821.8 | 19.4% |
| Sales revenues of Pharma | 815.2 | 805.0 | 1.3% |
| Podravka Group's profitability (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Group's gross profit | 1,518.9 | 1,385.1 | 9.7% |
| Group's gross profit margin | 36.3% | 38.2% | -190 bp |
| Group's EBITDA | 469.6 | 468.6 | 0.2% |
| Group's EBITDA margin | 11.2% | 12.9% | -170 bp |
| Group's EBIT | 268.9 | 285.2 | -5.7% |
| Group's EBIT margin | 6.4% | 7.9% | -144 bp |
| Group's net profit after MI | 182.4 | 397.3 | -54.1% |
| Group's net profit margin after MI | 4.4% | 11.0% | -660 bp |
| Podravka Group's balance sheet (in HRKm) | 31.12.2016 | 31.12.2015 | % change |
| Total assets | 5,285.7 | 4,991.6 | 5.9% |
| Shareholders' equity | 2,877.2 | 2,750.0 | 4.6% |
| Minority interests | 49.2 | 67.7 | -27.3% |
| Cash and cash equivalents | 337.6 | 291.9 | 15.7% |
| Financial debt | 1,379.4 | 1,214.3 | 13.6% |
| Net debt | 1,041.7 | 922.4 | 12.9% |
| Podravka Group's cash flow (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Net cash flow from operating activities | 476.7 | 274.2 | 73.8% |
| Capital expenditures | 437.1 | 271.2 | 61.2% |
| Depreciation and amortization | 191.4 | 148.3 | 29.1% |
| Free cash flow | 39.6 | 3.0 | 1226.2% |
| Podravka Group's ratios and indicators | 2016 | 2015 | % change |
| Employee number at the end of period (in units) | 6,404 | 6,657 | -3.8% |
| P&L interest expense (in HRKm) | 31.5 | 36.9 | -14.8% |
| Sales revenues / Number of employees (in HRK000) | 653.6 | 544.8 | 20.0% |
| Net profit after MI / Sales revenues (in HRK000) | 28.5 | 59.7 | -52.3% |
| Return on average assets | 3.7% | 9.5% | -583 bp |
| Return on average capital | 6.5% | 17.5% | -1098 bp |
| Return on average invested capital | 5.7% | 8.9% | -322 bp |
| Total shareholders' equity / Total assets | 55.4% | 56.5% | -109 bp |
| EBIT / P&L interest expense | 8.5 | 7.7 | 10.6% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,044.3 | 2,503.6 | 21.6% |
| Sales revenues of Podravka Group | 3,030.8 | 2,462.2 | 23.1% |
| Sales revenues of Food | 2,465.2 | 1,897.8 | 29.9% |
| Sales revenues of Pharma | 565.7 | 564.3 | 0.2% |
| Podravka Group's profitability (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Group's gross profit | 1,104.1 | 957.2 | 15.3% |
| Group's gross profit margin | 36.4% | 38.9% | -245 bp |
| Group's EBITDA | 337.4 | 276.5 | 22.0% |
| Group's EBITDA margin | 11.1% | 11.2% | -10 bp |
| Group's EBIT | 201.2 | 166.8 | 20.6% |
| Group's EBIT margin | 6.6% | 6.8% | -14 bp |
| Group's net profit after MI | 142.2 | 131.0 | 8.6% |
| Group's net profit margin after MI | 4.7% | 5.3% | -63 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2016 | 31.12.2015 | % change |
| Total assets | 5,082.4 | 4,945.8 | 2.8% |
| Shareholders' equity | 2,828.3 | 2,750.0 | 2.8% |
| Minority interests | 48.2 | 67.7 | -28.8% |
| Cash and cash equivalents | 219.4 | 291.9 | -24.8% |
| Financial debt | 1,375.0 | 1,214.3 | 13.2% |
| Net debt | 1,155.6 | 922.4 | 25.3% |
| Podravka Group's cash flow (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Net cash flow from operating activities | 299.3 | 32.3 | 826.9% |
| Capital expenditures | 383.7 | 144.7 | 165.2% |
| Depreciation and amortization | 136.1 | 101.2 | 34.5% |
| Free cash flow | (84.4) | (112.4) | -24.9% |
| Podravka Group's ratios and indicators | 1-9 2016. | 2015 | % change |
| Employee number at the end of period (in units) | 6,754 | 6,657 | 1.5% |
| P&L interest expense (in HRKm) | 35.0 | 36.9 | -5.2% |
| Sales revenues / Number of employees (in HRK000) | 621.2 | 544.8 | 14.0% |
| Net profit after MI / Sales revenues (in HRK000) | 60.5 | 59.7 | 1.3% |
| Return on average assets | 8.4% | 9.5% | -114 bp |
| Return on average capital | 14.7% | 17.5% | -281 bp |
| Return on average invested capital | 8.8% | 8.9% | -10 bp |
| Total shareholders' equity / Total assets | 56.6% | 56.5% | -38 bp |
| EBIT / P&L interest expense | 9.1 | 7.7 | 18.3% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,998.4 | 1,613.7 | 23.8% |
| Sales revenues of Podravka Group | 1,988.5 | 1,576.3 | 26.2% |
| Sales revenues of Food | 1,609.5 | 1,198.7 | 34.3% |
| Sales revenues of Pharma | 379.1 | 377.6 | 0.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Group's gross profit | 723.8 | 614.3 | 17.8% |
| Group's gross profit margin | 36.4% | 39.0% | -257 bp |
| Group's EBITDA | 222.0 | 196.1 | 13.2% |
| Group's EBITDA margin | 11.2% | 12.4% | -128 bp |
| Group's EBIT | 129.8 | 123.2 | 5.4% |
| Group's EBIT margin | 6.5% | 7.8% | -129 bp |
| Group's net profit after MI | 97.3 | 91.9 | 5.8% |
| Group's net profit margin after MI | 4.9% | 5.8% | -94 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2016 | 31.12.2015 | % change |
| Total assets | 4,947.9 | 4,945.8 | 0.0% |
| Shareholders' equity | 2,835.3 | 2,750.0 | 3.1% |
| Minority interests | 46.6 | 67.7 | -31.2% |
| Cash and cash equivalents | 242.2 | 291.9 | -17.0% |
| Financial debt | 1,264.3 | 1,214.3 | 4.1% |
| Net debt | 1,022.1 | 922.4 | 10.8% |
| Podravka Group's cash flow (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Net cash flow from operating activities | 142.0 | (11.9) | n/a |
| Capital expenditures | 233.1 | 60.6 | 284.7% |
| Depreciation and amortization | 92.2 | 67.3 | 36.9% |
| Free cash flow | (91.1) | (72.5) | 25.6% |
| Podravka Group's ratios and indicators | 1-6 2016 | 2015 | % change |
| Employee number at the end of period (in units) | 6,672 | 6,657 | 0.2% |
| P&L interest expense (in HRKm) | 35.6 | 36.9 | -3.6% |
| Sales revenues / Number of employees (in HRK000) | 605.4 | 544.8 | 11.1% |
| Net profit after MI / Sales revenues (in HRK000) | 60.4 | 59.7 | 1.1% |
| Return on average assets | 8.3% | 9.5% | -115 bp |
| Return on average capital | 14.5% | 17.5% | -306 bp |
| Return on average invested capital | 7.6% | 8.9% | -130 bp |
| Total shareholders' equity / Total assets | 58.2% | 56.5% | +127 bp |
| EBIT / P&L interest expense | 8.1 | 7.7 | 4.4% |
| Net debt / EBITDA | 2.1 | 2.0 | 5.0% |
Notes:
Possible decimal differences due to rounding.
Financial debt = Non-current and current borrowings + Financial liabilities at fair value through profit and loss.
Net debt = Financial debt - Cash and cash equivalents.
Free cash flow = Net cash flow from operating activities - Capital expenditures.
Return on average assets = Net profit / Average total assets.
Return on average equity = Net profit / Average total shareholders' equity.
Return on average invested capital = EBIT*0.82 / (Average total shareholders' equity + average financial debt - average cash and cash equivalents).
Ratios and indicators have been calculated on the TTM basis.
